Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – McVicar Website

Daniel W. McVicar, Ph.D.

Selected Publications

1)  Montalvo V, Quigley L, Vistica BP, Boelte KC, Nugent LF, Takai T, McVicar DW, Gery I.
Environmental Factors Determine DAP12 Deficiency To Either Enhance or Suppress Immunopathogenic Processes.
Immunology. 2013.
2)  Orr SJ, Burg AR, Chan T, Quigley L, Jones GW, Ford JW, Hodge D, Razzook C, Sarhan J, Jones YL, Whittaker GC, Boelte KC, Lyakh L, Cardone M, O'Connor GM, Tan C, Li H, Anderson SK, Jones SA, Zhang W, Taylor PR, Trinchieri G, McVicar DW.
LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-? production by repressing ß-catenin activation in dendritic cells.
PLoS Pathog. 9: e1003357, 2013.
3)  O'Connor GM, Basatena NS, Olavarria V, Macnamara A, Vine A, Ying Q, Hisada M, Galvão-Castro B, Asquith B, McVicar DW.
In Contrast to HIV, KIR3DS1 Does Not Influence Outcome In HTLV-1 Retroviral Infection.
Hum. Immunol. 73: 783-7, 2012.
4)  Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, Massin F, Max JP, Ford J, Alauzet C, Levy B, McVicar DW, Gibot S.
Soluble Trem-like Transcript-1 Regulates Leukocyte Activation and Controls Microbial Sepsis.
J. Immunol. 188: 5585-92, 2012.
5)  O'Connor GM, Yamada E, Rampersaud A, Thomas R, Carrington M, McVicar DW.
Analysis of Binding of KIR3DS1*014 to HLA Suggests Distinct Evolutionary History of KIR3DS1.
J. Immunol. 187: 2162-71, 2011.
6)  Fadda L, O'Connor GM, Kumar S, Piechocka-Trocha A, Gardiner CM, Carrington M, McVicar DW, Altfeld M.
Common HIV-1 Peptide Variants Mediate Differential Binding of KIR3DL1 to HLA-Bw4 Molecules.
J. Virol. 85: 5970-4, 2011.
7)  Vivian JP, Duncan RC, Berry R, O'Connor GM, Reid HH, Beddoe T, Gras S, Saunders PM, Olshina MA, Widjaja JM, Harpur CM, Lin J, Maloveste SM, Price DA, Lafont BA, McVicar DW, Clements CS, Brooks AG, Rossjohn J.
Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B.
Nature. 479: 401-5, 2011.
8)  Orr SJ, Roessler S, Quigley L, Chan T, Ford JW, O'Connor GM, McVicar DW.
Implications for gene therapy-limiting expression of IL-2Rgammac delineate differences in signaling thresholds required for lymphocyte development and maintenance.
J. Immunol. 185: 1393-403, 2010.
9)  Orr SJ, McVicar DW.
LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?.
J. Leukoc. Biol. 89: 11-9, 2010.
10)  Whittaker GC, Orr SJ, Quigley L, Hughes L, Francischetti IM, Zhang W, McVicar DW.
The linker for activation of B cells (LAB)/non-T cell activation linker (NTAL) regulates triggering receptor expressed on myeloid cells (TREM)-2 signaling and macrophage inflammatory responses independently of the linker for activation of T cells.
J. Biol. Chem. 285: 2976-85, 2010.
Click Here to View Expanded Bibliography.

This page was last updated on 9/10/2013.